Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,229 signal articles · 0 in last 24h · 160,153 total before filter · latest 2d ago
0last 24h
589last 7d
86● bullish (7d)
64● bearish (7d)
214publishers
AllMacro109Earnings163M&A60Regulatory12Product10Analyst17
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
PayPal (PYPL) Stock Gets Fair Value Trim As Analysts Weigh Q2 And Deal Uncertainty
Simply Wall St.15d agoneutral
PayPal (PYPL) Stock Gets Fair Value Trim As Analysts Weigh Q2 And Deal Uncertainty

Analysts have trimmed their central fair value estimate for PayPal Holdings, with the model price target moving from US$59.16 to US$57.07. The revision comes amid mixed research views, with some analysts highlighting Q2 earnings and asset value, while others focus on competition, questions about a takeover, and recent share moves linked to deal headlines. As you read on, you will see how this updated target fits into the broader PayPal narrative and what signals to watch next. Analyst Price...

United Airlines Holdings (UAL), What Is Drawing Fresh Attention To The Airline?
Simply Wall St.15d agoneutral
United Airlines Holdings (UAL), What Is Drawing Fresh Attention To The Airline?

United Airlines Holdings (UAL) just connected rising fuel costs, fare increases and a new in-flight entertainment push, including live football via a DISH Network and Starlink partnership, into a broader strategy focused on profitability. Recent trading reflects that mix of cost pressure and product upgrades. United Airlines Holdings has a 30 day share price return that fell 9.33% and a 90 day share price return down 9.03%. However, the 3 year total shareholder return of 146.37% and 5 year...

What Does Eli Lilly (LLY) Gain From Its New Genetic Medicine Partnership?
Simply Wall St.15d agobullish
What Does Eli Lilly (LLY) Gain From Its New Genetic Medicine Partnership?

Eli Lilly (NYSE:LLY) has entered an exclusive research collaboration with QurCan Therapeutics to develop genetic medicines for nervous system diseases. The agreement centers on QurCan's polymer lipid nanoparticle delivery platform for central and peripheral nervous system targets, with Eli Lilly responsible for later development and commercialization. Lilly is also making a strategic investment in QurCan Therapeutics, tying capital directly to progress in genetic medicine delivery...

3 Software Stocks That Fall Short
StockStory15d agobearish
3 Software Stocks That Fall Short

Software is eating the world, and virtually no business is left untouched by it. The undeniable tailwinds fueling the industry have also led to strong returns for SaaS stocks lately as they’ve gained 39.4% over the past six months, outpacing the S&P 500’s 14% rise.

Major Wendy’s franchisee declares bankruptcy
Restaurant Dive15d agobearish
Major Wendy’s franchisee declares bankruptcy

Meritage Hospitality Group, which operates 314 Wendy’s units, has closed at least 60 units and opted out or altered the breakfast daypart to improve store-level EBITDA.

Marriott appoints loyalty SVP
Hotel Dive15d agoneutral
Marriott appoints loyalty SVP

Chris Buckner joins the company as it looks to enhance the “meaningful experiences” it offers to Marriott Bonvoy members, per Chief Customer Officer Peggy Roe.

Vicor Stock Surges 18% Following AI License Agreement
TIKR15d agobullish
Vicor Stock Surges 18% Following AI License Agreement

Key Stats for Vicor StockPrice change for Vicor stock in last 1 year: 302%$VICR Stock Price as of Sep. 17: $21652-Week High: $383$VICR Stock Price Target: $386What Happened?Vicor (VICR) stock jumped about 18% on Thursday after the company announced a new licensing deal tied to the booming AI infrastructure market.

Forkast News15d agoneutral
Coinbase Just Embedded Its Rails Inside 4,000-Plus Community Banks

The stablecoin wars have shifted from the issuers—Circle, Ripple, and Ondo—to the infrastructure of global finance. Rather than fighting for dominance within crypto-native exchanges, the industry is now focused on the plumbing required to move assets into the mainstream. Coinbase is betting that the true battleground for stablecoin adoption is not the digital wallet, but […]

Meta’s AI Agent Has a Trust Problem
The Wall Street Journal15d agoneutral
Meta’s AI Agent Has a Trust Problem

Last week, Meta rolled out Muse, Chief Executive Mark Zuckerberg’s “personal AI agent built for everyone.” In Meta’s telling, it also democratizes AI. Zuckerberg first described his vision for “personal superintelligence” last year and previewed Muse in an August essay where he spoke of “putting power in people’s hands to pursue their own aspirations.”